Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGLEC7 | Q9Y286 | 6/20 | 0.70 |
| ▸ | MAG | P20916 | 9/20 | 0.67 |
| ▸ | SELP | P16109 | 2/20 | 0.66 |
| ▸ | SELL | P14151 | 1/20 | 0.66 |
| ▸ | SELE | P16581 | 2/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29390469 | 1.00 | SIGLEC7 (0.70) | SIGLEC7MAGSELPSELLSELE | |
| SCHEMBL25658073 | 1.00 | SIGLEC7 (0.70) | SIGLEC7MAGSELPSELLSELE | |
| SCHEMBL29376404 | 1.00 | SIGLEC7 (0.70) | SIGLEC7MAGSELPSELLSELE | |
| SCHEMBL30001490 | 1.00 | SIGLEC7 (0.70) | SIGLEC7MAGSELPSELLSELE | |
| SCHEMBL14362211 | 1.00 | SIGLEC7 (0.70) | SIGLEC7MAGSELPSELLSELE | |
| SCHEMBL19922285 | 1.00 | SIGLEC7 (0.70) | SIGLEC7MAGSELPSELLSELE | |
| SCHEMBL24529621 | 1.00 | SIGLEC7 (0.70) | SIGLEC7MAGSELPSELLSELE | |
| SCHEMBL29357459 | 1.00 | SIGLEC7 (0.70) | SIGLEC7MAGSELPSELLSELE | |
| SCHEMBL20885234 | 1.00 | SIGLEC7 (0.70) | SIGLEC7MAGSELPSELLSELE | |
| SCHEMBL25662685 | 1.00 | SIGLEC7 (0.70) | SIGLEC7MAGSELPSELLSELE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3681504-B1 | METHODS OF DETECTION USING X-RAY FLUORESCENCE | ICAGEN INC (US) | 2023-08-23 | — | — | EP | disclosed |
| US-11573224-B2 | Methods of detection using X-ray fluorescence | ICAGEN, LLC (US) | 2023-02-07 | — | — | US | disclosed |
| US-11446398-B2 | Regulated biocircuit systems | OBSIDIAN THERAPEUTICS, INC. (US) | 2022-09-20 | — | — | US | disclosed |
| US-20210254056-A1 | IDENTIFICATION AND TARGETED MODULATION OF GENE SIGNALING NETWORKS | CAMP4 THERAPEUTICS CORPORATION | 2021-08-19 | — | — | US | disclosed |
| US-10877035-B2 | Advanced drug development and manufacturing | ICAGEN, LLC (US) | 2020-12-29 | — | — | US | disclosed |
| US-20200278346-A1 | METHODS OF DETECTION USING X-RAY FLUORESCENCE | ADJACENT ACQUISITION CO., LLC | 2020-09-03 | — | — | US | disclosed |
| US-20190192691-A1 | REGULATED BIOCIRCUIT SYSTEMS | OBSIDIAN THERAPEUTICS, INC. | 2019-06-27 | — | — | US | disclosed |
| WO-2018204764-A1 | IDENTIFICATION AND TARGETED MODULATION OF GENE SIGNALING NETWORKS | CAMP4 THERAPEUTICS CORPORATION (US) | 2018-11-08 | — | — | WO | disclosed |
| CN-107207485-A | Crystalline forms of (S) -5-benzyl-N- (5-methyl-4-oxo-2, 3,4, 5-tetrahydrobenzo [ b ] [1,4] oxazepin-3-yl) -4H-1,2, 4-triazole-3-carboxamide | 葛兰素史密斯克莱知识产权发展有限公司 | 2017-09-26 | — | — | CN | disclosed |
| CN-106998774-A | Infant formula comprising human milk oligosaccharides, polyunsaturated fatty acids, nucleotides and lutein | 雅培制药有限公司 | 2017-08-01 | — | — | CN | disclosed |
| CN-106998775-A | Infant formula with RRR-alpha-tocopherol, 2' -fucosyllactose, and probiotics | 雅培制药有限公司 | 2017-08-01 | — | — | CN | disclosed |
| US-20150309021-A1 | Advanced Drug Development and Manufacturing | LOS ALAMOS NATIONAL SECURITY, LLC | 2015-10-29 | — | — | US | disclosed |
| EP-2511844-B1 | X-ray microscope | XRPRO SCIENCES INC (US) | 2015-08-12 | — | — | EP | disclosed |
| CN-104780785-A | Method for increasing brain functionality using 2-fucosyllactose | ABBOTT LAB | 2015-07-15 | — | — | CN | disclosed |
| EP-2511844-A2 | Advanced drug development and manufacturing | Los Alamos National Security, LLC (US) | 2012-10-17 | — | — | EP | disclosed |
| EP-2084519-B1 | X-RAY FLUORESCENCE ANALYSIS METHOD | LOS ALAMOS NAT SECURITY LLC (US) | 2012-08-01 | — | — | EP | disclosed |
| EP-2084519-A2 | ADVANCED DRUG DEVELOPMENT AND MANUFACTURING | Los Alamos National Security, LLC (US) | 2009-08-05 | — | — | EP | disclosed |
| WO-2008127291-A2 | ADVANCED DRUG DEVELOPMENT AND MANUFACTURING | LOS ALAMOS NATIONAL SECURITY, LLC (US) | 2008-10-23 | — | — | WO | disclosed |
| US-20080220441-A1 | Advanced drug development and manufacturing | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2008-09-11 | — | — | US | disclosed |